The prognostic effect of residual tumor for advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy or primary debulking surgery-Reference-Cited by-同舟云学术

The prognostic effect of residual tumor for advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy or primary debulking surgery

Published:2022-03-10 Issue:14 Volume:11 Page:2836-2845
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Yang Shi‐Ping¹,Chen Jian‐Xian²,Xu Jing‐Ying³,Lei Jian³,Wu San‐Gang⁴^ORCID,Zhou Juan

Affiliation:

1. Department of Radiation Oncology Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University) Haikou People's Republic of China

2. Department of Medical Oncology People's Hospital of Baise Baise People's Republic of China

3. Department of Obstetrics and Gynecology, the First Affiliated Hospital of Xiamen University School of Medicine, Xiamen University Xiamen People's Republic of China

4. Department of Radiation Oncology, the First Affiliated Hospital of Xiamen University School of Medicine, Xiamen University Xiamen People's Republic of China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4642

Reference37 articles.

1. Ovarian cancer statistics, 2018

2. ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

3. Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology